NCT03901495

Brief Summary

Single-center, unblinded, 1:1 parallel pseudo-randomized efficacy trial. In the intervention group only, resident physicians will be assisted by the automated medical history-taking device "Diaana" during their consultations in outpatient ambulatory unit of the Geneva University Hospital. In both groups, the differential diagnosis of the resident physician will be compared to the gold-standard differential diagnosis of the senior physician.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2019

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 2, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 3, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
Last Updated

November 10, 2020

Status Verified

November 1, 2020

Enrollment Period

1.1 years

First QC Date

March 2, 2019

Last Update Submit

November 7, 2020

Conditions

Keywords

differential diagnosishospital outpatient clinicsclinical applications software

Outcome Measures

Primary Outcomes (1)

  • Differential diagnosis established by the resident physician

    The resident physician will select up to 5 diagnose in an exhaustive list. The senior physician will do the same in order to establish the gold-standard differential diagnosis. The accuracy of the resident's differential diagnosis will be measured as the percentage of correct diagnose selected by the resident compared to the gold standard.

    At day 0

Secondary Outcomes (3)

  • Consultation time

    At day 0

  • Patient satisfaction

    At day 0

  • Differential diagnosis estabished by Diaana

    At day 0

Study Arms (2)

Diaana

EXPERIMENTAL

1. The patient fullfill Diaana 2. The resident physician takes connaissance of the Diaana summary 3. The resident physician see the patient in consultation. He establishes his DD without having access to the complementay exams (blood tests, x-ray, ...) 4. The senior physician see the patient in consultation. He establishes his DD without having access to the complementay exams (blood tests, x-ray, ...)

Other: Diaana

Control

NO INTERVENTION

1. The resident physician see the patient in consultation. He establishes his DD without having access to the complementay exams (blood tests, x-ray, ...) 2. The senior physician see the patient in consultation. He establishes his DD without having access to the complementay exams (blood tests, x-ray, ...)

Interventions

DiaanaOTHER

Diaana, the AMHTD used, functions as follows: on the basis of an interactive questionnaire completed by the patient before the consultation, it performs an exhaustive anamnesis focused on the problem and proposes a panel of DDs with a high sensitivity. The artificial reasoning system of "Diaana" mimics how a specialist physician would reason to establish a DD. The information transmitted is in an easy-to-use form for the physician that includes a summary of the anamnesis centered on relevant elements from the questionnaire and a list of possible diagnoses with their emergency level, potential contributing factors, and first-line management proposals.

Also known as: Automated medical history-taking device (AMHTD)
Diaana

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients presenting to the emergency outpatient unit of Geneva University Hospital
  • Patients suffering from symptoms localized to the superior or inferior member, the back, hand the chest wall.

You may not qualify if:

  • Strictly dermatologic concerns
  • Toes and inversion ankle trauma (because the diagnosis of those conditions is generally obvious)
  • Medical condition considered as urgent
  • Inability to complete de digilatized Diaana form (sight problems, language, inability to use a tablet computer)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geneva University Hospital

Geneva, 1205, Switzerland

Location

Related Publications (1)

  • Healey B, Schwitzguebel A, Spechbach H. Differential Diagnosis Assessment in Ambulatory Care With a Digital Health History Device: Pseudorandomized Study. JMIR Form Res. 2025 Oct 1;9:e56384. doi: 10.2196/56384.

MeSH Terms

Conditions

Patient Participation

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Hervé Spechbach, MD

    University Hospital, Geneva

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
The first 50 eligible patients of the emergency outpatient unit in Geneva University Hospital are recruited into the control group (without access to "Diaana"). The next 50 eligible patients are recruited into the intervention group (with access to "Diaana").
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator, Independant physician

Study Record Dates

First Submitted

March 2, 2019

First Posted

April 3, 2019

Study Start

February 28, 2019

Primary Completion

March 31, 2020

Study Completion

March 31, 2020

Last Updated

November 10, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will share

De-identified individual participant data for all primary and secondary outcomes measures will be made avaliable

Shared Documents
SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will be avaliable within 3 months of the study completion
Access Criteria
Under request to the sponsor.

Locations